Company Description
Waldencast plc operates in the beauty and wellness industry in the United States, Canada, Europe, the Middle East, India, Australia, and New Zealand.
The company operates through two segments, Obagi Medical and Milk Makeup. It offers skin care products to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and protect and enhance skin tone and texture; cosmetics; and other beauty products.
In addition, the company provides foundation, concealer, primer, blush, setting spray, and bronzer categories, as well as sells liner, eyeshadow, and lip color products.
It serves distributors, retailers, physicians, and directly to consumers through its e-commerce platforms, and third-party logistics and delivery providers.
The company was incorporated in 2020 and is headquartered in White Plains, New York.
| Country | United States |
| Founded | 1988 |
| IPO Date | Mar 16, 2021 |
| Industry | Shell Companies |
| Sector | Financials |
| Employees | 284 |
| CEO | Michel Brousset |
Contact Details
Address: 10 Bank Street, Suite 560 White Plains, New York 10606 United States | |
| Website | waldencast.com |
Stock Details
| Ticker Symbol | WALD |
| Exchange | NASDAQ |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $10.00 |
| CIK Code | 0001840199 |
| CUSIP Number | G9503X103 |
| ISIN Number | JE00BPG99318 |
| SIC Code | 2844 |
Key Executives
| Name | Position |
|---|---|
| Michel Brousset | Founder, Chief Executive Officer and Director |
| Hind Sebti | Co-Founder, Chief Growth Officer and Director |
| Manuel Manfredi | Chief Financial Officer |
| Elisabeth Milan | General Counsel |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 31, 2025 | SCHEDULE 13D/A | Filing |
| Jul 23, 2025 | 6-K | Report of foreign issuer |
| May 19, 2025 | SCHEDULE 13G | Filing |
| May 14, 2025 | 6-K | Report of foreign issuer |
| May 13, 2025 | 6-K | Report of foreign issuer |
| Mar 20, 2025 | 20-F | Annual and transition report of foreign private issuers |
| Mar 19, 2025 | 6-K | Report of foreign issuer |
| Mar 18, 2025 | 6-K | Report of foreign issuer |
| Jan 30, 2025 | SCHEDULE 13D/A | Filing |
| Nov 22, 2024 | 144 | Filing |